Table 4.

Univariate analysis for progression-free survival (PFS), distant metastasis-free (DMFS) survival and cause specific survival (CSS) rates

		PFS		DMFS		CSS
	N	3 years %	P	3 years %	p	3 years %	P
T stage
T1+T2	16	100		100		100
			0.004		0.07		0.004
T3+T4	25	59		81		58
Nodal stage
N0-1	2	100		100		100
			0.45		0.65		0.46
N2-3	39	74		89		73
Treatment type
Induc CT-CTRT	30	72		89		72
			0.6				0.59
Induct CT-RT	11	82		91	0.93	82